Home
>
National Drug Code (NDC)
>
ATACAND HCT
ATACAND HCT - 0186-0322-54 - (Candesartan cilexetil and Hydrochlorothiazide)
Drug Information of ATACAND HCT
| Product NDC: | 0186-0322 |
| Proprietary Name: | ATACAND HCT |
| Non Proprietary Name: | Candesartan cilexetil and Hydrochlorothiazide |
| Active Ingredient(s): | 32; 12.5 mg/1; mg/1 & nbsp; Candesartan cilexetil and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ATACAND HCT
| Product NDC: | 0186-0322 |
| Labeler Name: | AstraZeneca LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021093 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000928 |
Package Information of ATACAND HCT
| Package NDC: | 0186-0322-54 |
| Package Description: | 90 TABLET in 1 BOTTLE (0186-0322-54) |
NDC Information of ATACAND HCT
| NDC Code | 0186-0322-54 |
| Proprietary Name | ATACAND HCT |
| Package Description | 90 TABLET in 1 BOTTLE (0186-0322-54) |
| Product NDC | 0186-0322 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Candesartan cilexetil and Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20000928 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca LP |
| Substance Name | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE |
| Strength Number | 32; 12.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
